UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 456

Sortiert nach

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

The New England journal of medicine, 2021-02, Vol.384 (6), p.541-549

2021

Volltextzugriff (PDF)

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010179-e1010179

2022

Volltextzugriff (PDF)

Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1

PloS one, 2020-02, Vol.15 (2), p.e0229570-e0229570

2020

Volltextzugriff (PDF)

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

PLoS pathogens, 2014-05, Vol.10 (5), p.e1004082-e1004082

2014

Volltextzugriff (PDF)

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

Cell reports (Cambridge), 2021-03, Vol.34 (11), p.108863, Article 108863

2021

Volltextzugriff (PDF)

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology

Clinical infectious diseases, 2022-01, Vol.74 (2), p.254-262

2022

Volltextzugriff (PDF)

Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19

PloS one, 2022-05, Vol.17 (5), p.e0268296

2022

Volltextzugriff (PDF)

Monocytes Activate Natural Killer Cells via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication

Gastroenterology (New York, N.Y. 1943), 2014-07, Vol.147 (1), p.209-220.e3

2014

Volltextzugriff (PDF)

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

The Lancet infectious diseases, 2012-05, Vol.12 (5), p.408-414

2012

Volltextzugriff (PDF)

A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

Clinical cancer research, 2012-02, Vol.18 (3), p.858-868

2012

Volltextzugriff (PDF)

Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design

PLoS pathogens, 2016-06, Vol.12 (6), p.e1005632-e1005632

2016

Volltextzugriff (PDF)

Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

Cell host & microbe, 2018-11, Vol.24 (5), p.717-730.e5

2018

Volltextzugriff (PDF)

Plasma virome and the risk of blood-borne infection in persons with substance use disorder

Nature communications, 2021-11, Vol.12 (1), p.6909-6909, Article 6909

2021

Volltextzugriff (PDF)

Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children

The Journal of clinical investigation, 2023-11, Vol.133 (21)

2023

Volltextzugriff (PDF)

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.418-430

2019

Volltextzugriff (PDF)

Erratum for Karaba et al., "Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment"

mBio, 2024-04, Vol.15 (4), p.e0057224-e0057224

2024

Volltextzugriff (PDF)

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro

Hepatology (Baltimore, Md.), 2010-11, Vol.52 (5), p.1581-1589

2010

Volltextzugriff (PDF)

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

The Journal of clinical investigation, 2022-08, Vol.132 (15)

2022

Volltextzugriff (PDF)

Long-Read Nanopore-Based Sequencing of Anelloviruses

Viruses, 2024-05, Vol.16 (5), p.723

2024

Volltextzugriff (PDF)

Challenges and Promise of a Hepatitis C Virus Vaccine

Cold Spring Harbor perspectives in medicine, 2020-02, Vol.10 (2), p.a036947

Cox, Andrea L

2020

Volltextzugriff (PDF)

Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Frontiers in immunology, 2023-03, Vol.14, p.1135841-1135841

2023

Volltextzugriff (PDF)

The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design

The Journal of infectious diseases, 2012-05, Vol.205 (9), p.1342-1350

2012

Volltextzugriff (PDF)

Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients

Open forum infectious diseases, 2023-01, Vol.10 (1), p.ofac677

2023

Volltextzugriff (PDF)

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19

Biomedicines, 2021-08, Vol.9 (9), p.1090

2021

Volltextzugriff (PDF)

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Frontiers in immunology, 2023-04, Vol.14, p.1201033-1201033

2023

Volltextzugriff (PDF)

1 – 25 von 456

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(431)
Mit Volltextzugriff
(412)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology

Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19

Monocytes Activate Natural Killer Cells via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design

Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

Plasma virome and the risk of blood-borne infection in persons with substance use disorder

Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

Erratum for Karaba et al., "Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment"

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

Long-Read Nanopore-Based Sequencing of Anelloviruses

Challenges and Promise of a Hepatitis C Virus Vaccine

Convergent antibody responses are associated with broad neutralization of hepatitis C virus

The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design

Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Suchergebnisse filtern